Emerging Targets in Gastrointestinal (Gastric & Gastroesophageal) Cancers – Clinical Brief #2 Evaluation (ID: i832-2) Question Title * 1. How many years have you been in practice? >21 11-20 1-10 <1 Question Title * 2. How many patients with GI cancer do you manage per week? 1 to 10 11 to 25 26 to 50 I am not directly involved in patient care Question Title * 3. Please select the option that best describes your practice: Academic medical center Community medical center VA, DOD, or other government Managed care Research Pharmaceutical industry Question Title * 4. After participating in this activity, how confident are you now in the management of patients with GI cancer in your practice? Very confident Confident Neutral Little confidence No confidence Question Title * 5. How committed are you to making changes in your practice based on your participation in this activity? Very committed Committed Neutral Not committed I do not plan to make changes If not committed or do not plan to make changes, please indicate reason Question Title * 6. Which of the following best describes the impact of this activity on your performance? I gained new strategies/skills/information I can apply to my area of practice I need more information before I can change my practice My practice is already consistent with the information presented This activity will not change my practice Question Title * 7. Which new strategies/skills/information will you apply to your area of practice? Please select all that apply. Increased familiarity with guideline-recommended biomarker testing Increased familiarity with biomarker testing methods Increased ability to select targeted therapy based on biomarker testing results Question Title * 8. What barriers do you see to making changes in your practice? Please select all that apply. Lack of knowledge regarding evidence-based strategies Lack of convincing evidence to warrant change Lack of time/resources to consider change Insurance, reimbursement or legal issues Conflicting guidelines or evidence Patient compliance and/or patient resource barriers Other (please specify) Question Title * 9. Please rate your level of agreement by checking the appropriate rating.After participating in today’s activity, I am now better able to: Strongly agree Agree Neutral Disagree Strongly disagree Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Strongly agree Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Agree Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Neutral Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Disagree Select optimal testing methods and timing for patients diagnosed with gastric, gastroesophageal, and gastroesophageal junction cancer Strongly disagree Assess testing methods and interpretation for currently approved molecular biomarkers Assess testing methods and interpretation for currently approved molecular biomarkers Strongly agree Assess testing methods and interpretation for currently approved molecular biomarkers Agree Assess testing methods and interpretation for currently approved molecular biomarkers Neutral Assess testing methods and interpretation for currently approved molecular biomarkers Disagree Assess testing methods and interpretation for currently approved molecular biomarkers Strongly disagree Question Title * 10. Please rate your level of agreement by checking the appropriate rating. Strongly agree, Agree, Neutral, Disagree, Strongly disagree Strongly agree Agree Neutral Disagree Strongly disagree Faculty for this activity was effective Faculty for this activity was effective Strongly agree Faculty for this activity was effective Agree Faculty for this activity was effective Neutral Faculty for this activity was effective Disagree Faculty for this activity was effective Strongly disagree Content was scientifically rigorous and evidence based Content was scientifically rigorous and evidence based Strongly agree Content was scientifically rigorous and evidence based Agree Content was scientifically rigorous and evidence based Neutral Content was scientifically rigorous and evidence based Disagree Content was scientifically rigorous and evidence based Strongly disagree Avoided commercial bias or influence Avoided commercial bias or influence Strongly agree Avoided commercial bias or influence Agree Avoided commercial bias or influence Neutral Avoided commercial bias or influence Disagree Avoided commercial bias or influence Strongly disagree Question Title * 11. As a result of your participation in this activity, what is the one change you are most likely to implement in your practice? Question Title * 12. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for GI (Gastric & Gastroesophageal) cancers. Question Title * 13. If you indicated that you perceived commercial bias or influence, please describe: Done